3-(difluoromethyl)-N-[1-(4-hydroxybutan-2-yl)-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide
C23H24F2N4O4 — CID 126688543
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(difluoromethyl)-N-[1-(4-hydroxybutan-2-yl)-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide
3-(difluoromethyl)-N-[1-(4-hydroxybutan-2-yl)-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide (PubChem CID 126688543) has the molecular formula C23H24F2N4O4 and a molecular weight of 458.47 g/mol. Its IUPAC name is 3-(difluoromethyl)-N-[1-(4-hydroxybutan-2-yl)-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide.
Molecular Properties
| Compound Name | 3-(difluoromethyl)-N-[1-(4-hydroxybutan-2-yl)-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide |
|---|---|
| PubChem CID | 126688543 |
| Molecular Formula | C23H24F2N4O4 |
| Molecular Weight | 458.47 g/mol |
| Exact Mass | 458.18 |
| IUPAC Name | 3-(difluoromethyl)-N-[1-(4-hydroxybutan-2-yl)-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide |
| SMILES | CC(CCO)n1c(NC(=O)c2cccc(C(F)F)c2)nc2cc(N3CCCOC3=O)ccc21 |
| InChI | InChI=1S/C23H24F2N4O4/c1-14(8-10-30)29-19-7-6-17(28-9-3-11-33-23(28)32)13-18(19)26-22(29)27-21(31)16-5-2-4-15(12-16)20(24)25/h2,4-7,12-14,20,30H,3,8-11H2,1H3,(H,26,27,31) |
| InChIKey | NVMASMAHHCGPAJ-UHFFFAOYSA-N |
| XLogP | 4.52 |
| TPSA | 96.69 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 458.47 |
| LogP ≤ 5 | 4.52 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126688543 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.